Joel Greenblatt's CRMD Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 31,365 shares of CorMedix Inc. (CRMD) worth $364,775, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in CRMD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's CorMedix (CRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CorMedix (CRMD) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +31,365 | New Buy | 31,365 | $11.63 |
Joel Greenblatt's CorMedix Investment FAQs
Joel Greenblatt first purchased CorMedix Inc. (CRMD) in Q3 2025, acquiring 31,365 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held CorMedix Inc. (CRMD) for 1 quarters since Q3 2025.
Joel Greenblatt's largest addition to CorMedix Inc. (CRMD) was in Q3 2025, adding 31,365 shares worth $364,775.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 31,365 shares of CorMedix Inc. (CRMD), valued at approximately $364,775.
As of the Q3 2025 filing, CorMedix Inc. (CRMD) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in CorMedix Inc. (CRMD) was 31,365 shares, as reported at the end of Q3 2025.